在乳腺癌局部精准治疗中的新进展：联合免疫治疗未来可期

周文斌; 谢晖; 丁强; 王水

doi:10.19401/j.cnki.1007-3639.2022.08.004

您当前的位置：

首页 >

文章列表页 >

在乳腺癌局部精准治疗中的新进展：联合免疫治疗未来可期

专家述评 | 更新时间：2025-12-31

- 在乳腺癌局部精准治疗中的新进展：联合免疫治疗未来可期
- New research progress of microwave ablation in the local precise treatment of early-stage breast cancer: the prospect of combined immunotherapy is promising
- 中国癌症杂志 2022年32卷第8期页码：698-704
- 作者机构：
  
  南京医科大学第一附属医院乳腺外科,江苏南京,210029
- 作者简介：
  
  [ "周文斌（ORCID: 0000-0003-1220-6797）,副主任医师,E-mail: zhouwenbin@njmu.edu.cn。" ]
  [ "王水,主任医师,教授,博士研究生导师,中国农工民主党江苏省委副主任委员,全国政协委员。现任江苏省妇幼保健院院长,江苏省人民医院副院长,江苏省乳腺疾病诊疗中心主任;中华医学会外科学分会内分泌乳腺外科学组委员,中国抗癌协会乳腺癌专业委员会委员,中国妇幼保健协会乳腺保健专业委员会主任委员,江苏省中西医结合学会副会长,江苏省中西医学会外科学分会主任委员,江苏省海外联谊会理事,江苏省质量协会副会长。现为国家自然科学基金、卫健委和教育部科研项目评审专家。江苏省135重点医学人才,江苏省六大人才高峰项目重点人才,333工程中青年学科带头人。从事乳腺疾病诊疗30余年,在乳腺癌早期诊断、保乳治疗、乳腺癌前哨淋巴结活检、难治性乳腺癌的综合治疗、乳腺疾病微创物理治疗、乳房再造等方面具有较高水平。主持国家和省级科研课题15项。主编医学著作3部。获得国家级教学成果奖1项、教育部科技成果奖1项、江苏省科技进步二等奖及三等奖各1 项。" ]
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2022.08.004
  中图分类号： R737.9
- 收稿：2022-06-12，
  
  修回：2022-07-09，
  
  纸质出版：2022-08-30
- 稿件说明：
移动端阅览
周文斌, 谢晖, 丁强, 等. 在乳腺癌局部精准治疗中的新进展：联合免疫治疗未来可期[J]. 中国癌症杂志, 2022,32(8):698-704.

Wenbin ZHOU, Hui XIE, Qiang DING, et al. New research progress of microwave ablation in the local precise treatment of early-stage breast cancer: the prospect of combined immunotherapy is promising[J]. China Oncology, 2022, 32(8): 698-704.
周文斌, 谢晖, 丁强, 等. 在乳腺癌局部精准治疗中的新进展：联合免疫治疗未来可期[J]. 中国癌症杂志, 2022,32(8):698-704. DOI： 10.19401/j.cnki.1007-3639.2022.08.004.

Wenbin ZHOU, Hui XIE, Qiang DING, et al. New research progress of microwave ablation in the local precise treatment of early-stage breast cancer: the prospect of combined immunotherapy is promising[J]. China Oncology, 2022, 32(8): 698-704. DOI： 10.19401/j.cnki.1007-3639.2022.08.004.

摘要

乳腺癌是女性最常见的恶性肿瘤

早期乳腺癌治疗以手术为主。目前

早期乳腺癌的诊治已取得了显著进展

但仍需要创新的方法来减少创伤和改善预后。随着乳腺癌治疗手段创新性研究的深入

乳房和腋窝的非手术治疗成为早期乳腺癌治疗的研究热点。微波消融作为一种微创的精准局部治疗方式

具有消融迅速、操作方式简易、术后并发症较少等特点

目前已尝试用于治疗早期乳腺癌

获得了较好的临床效果。此外

有研究报道

早期乳腺癌经微波消融可调节肿瘤免疫微环境

激发体内抗原特异性的抗肿瘤免疫反应。该免疫效应可能与微波消融后肿瘤抗原的大量释放有关。乳腺癌单用免疫治疗效果差

有研究者提出通过联合免疫治疗增强消融免疫效应的方案

但其具体疗效仍需要更多的临床数据支持。随着对于微波消融引起体内免疫效应的研究深入

微波治疗联合免疫检查点抑制剂疗法有望成为全新的精准治疗策略和理念。本文对微波消融在乳腺癌局部精准治疗中的应用研究新进展及未来发展方向进行总结。

Abstract

Breast cancer is the most common malignant tumor in women. Surgery is the main treatment for early breast cancer. At present

great progress has been made in the diagnosis and treatment of early breast cancer. Howover

innovative approaches are still needed to reduce trauma and improve patients' outcomes. With the progress of innovative research on the treatment of breast cancer

non-surgical treatment of breast and axilla has become a research hotspot of treatment of early breast cancer. Microwave ablation

as a minimally invasive and precise local treatment

has the characteristics of speedy ablation

simple operation method

less postoperative complications and so on. At present

microwave ablation has been used to treat early breast cancer

and has achieved clinical efficacy. In addition

some studies have been reported that microwave ablation of early breast cancer is conducive to regulating the tumor immune microenvironment and stimulating the antigen-specific anti-tumor immune effect in the body. This immune effect may be related to the massive release of tumor antigen after microwave ablation. The effect of immunotherapy alone for breast cancer is poor. Some researchers have proposed a scheme to enhance the ablation immune effect through combined immunotherapy

but its specific effect still needs more clinical data support. With more and more research on the immune effect induced by ablation therapy

microwave ablation combined with immune checkpoint inhibitor is expected to become a new strategy in the precise treatment of breast tumor. This article summarized the new progress and future development direction of microwave ablation in local precise treatment of breast cancer.

关键词

Keywords

references

YU M X , PAN H , CHE N , et al . Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells [J ] . Cell Mol Immunol , 2021 , 18 ( 9 ): 2153 - 2164 . DOI: 10.1038/s41423-020-0449-0 http://doi.org/10.1038/s41423-020-0449-0 https://doi.org/10.1038/s41423-020-0449-0 https://doi.org/10.1038/s41423-020-0449-0

PHD H S , JACQUES FERLAY MSC M , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA A Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.21660 http://doi.org/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660

SIEGEL R L , MILLER K D , FUCHS H E , et al . Cancer statistics, 2022 [J ] . CA Cancer J Clin , 2022 , 72 ( 1 ): 7 - 33 . DOI: 10.3322/caac.21708 http://doi.org/10.3322/caac.21708 https://onlinelibrary.wiley.com/doi/10.3322/caac.21708 https://onlinelibrary.wiley.com/doi/10.3322/caac.21708

FORNAGE B D , HUNT K K . Image-guided percutaneous ablation of small breast cancer: which technique is leading the pack? [J ] . Technol Cancer Res Treat , 2015 , 14 ( 2 ): 209 - 211 . DOI: 10.7785/tcrt.2012.500395 http://doi.org/10.7785/tcrt.2012.500395 http://journals.sagepub.com/doi/10.7785/tcrt.2012.500395 http://journals.sagepub.com/doi/10.7785/tcrt.2012.500395

CHU K F , DUPUY D E . Thermal ablation of tumours: biological mechanisms and advances in therapy [J ] . Nat Rev Cancer , 2014 , 14 ( 3 ): 199 - 208 . DOI: 10.1038/nrc3672 http://doi.org/10.1038/nrc3672 https://doi.org/10.1038/nrc3672 https://doi.org/10.1038/nrc3672

PETROWSKY H , FRITSCH R , GUCKENBERGER M , et al . Modern therapeutic approaches for the treatment of malignant liver tumours [J ] . Nat Rev Gastroenterol Hepatol , 2020 , 17 ( 12 ): 755 - 772 . DOI: 10.1038/s41575-020-0314-8 http://doi.org/10.1038/s41575-020-0314-8 https://doi.org/10.1038/s41575-020-0314-8 https://doi.org/10.1038/s41575-020-0314-8

AHMED M , BRACE C L , LEE F T , et al . Principles of and advances in percutaneous ablation [J ] . Radiology , 2011 , 258 ( 2 ): 351 - 369 . DOI: 10.1148/radiol.10081634 http://doi.org/10.1148/radiol.10081634 http://pubs.rsna.org/doi/10.1148/radiol.10081634 http://pubs.rsna.org/doi/10.1148/radiol.10081634

SIMMONS R M , BALLMAN K V , COX C , et al . A phase Ⅱ trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: results from ACOSOG (alliance) Z1072 [J ] . Ann Surg Oncol , 2016 , 23 ( 8 ): 2438 - 2445 . DOI: 10.1245/s10434-016-5275-3 http://doi.org/10.1245/s10434-016-5275-3 http://link.springer.com/10.1245/s10434-016-5275-3 http://link.springer.com/10.1245/s10434-016-5275-3

CAZZATO R L , DE LARA C T , BUY X , et al . Single-centre experience with percutaneous cryoablation of breast cancer in 23 consecutive non-surgical patients [J ] . Cardiovasc Intervent Radiol , 2015 , 38 ( 5 ): 1237 - 1243 . DOI: 10.1007/s00270-015-1181-5 http://doi.org/10.1007/s00270-015-1181-5 http://link.springer.com/10.1007/s00270-015-1181-5 http://link.springer.com/10.1007/s00270-015-1181-5

PALUSSIÈRE J , HENRIQUES C , MAURIAC L , et al . Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes [J ] . Radiology , 2012 , 264 ( 2 ): 597 - 605 . DOI: 10.1148/radiol.12111303 http://doi.org/10.1148/radiol.12111303 http://pubs.rsna.org/doi/10.1148/radiol.12111303 http://pubs.rsna.org/doi/10.1148/radiol.12111303

FINE R E , GILMORE R C , DIETZ J R , et al . Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial [J ] . Ann Surg Oncol , 2021 , 28 ( 10 ): 5525 - 5534 . DOI: 10.1245/s10434-021-10501-4 http://doi.org/10.1245/s10434-021-10501-4 https://doi.org/10.1245/s10434-021-10501-4 https://doi.org/10.1245/s10434-021-10501-4

SIMON C J , DUPUY D E , MAYO-SMITH W W . Microwave ablation: principles and applications [J ] . Radiographics , 2005 , 25 ( Suppl 1 ): S69 - S83 . DOI: 10.1148/rg.25si055501 http://doi.org/10.1148/rg.25si055501 http://pubs.rsna.org/doi/10.1148/rg.25si055501 http://pubs.rsna.org/doi/10.1148/rg.25si055501

ZHOU W B , ZHA X M , LIU X A , et al . US-guided percutaneous microwave coagulation of small breast cancers: a clinical study [J ] . Radiology , 2012 , 263 ( 2 ): 364 - 373 . DOI: 10.1148/radiol.12111901 http://doi.org/10.1148/radiol.12111901 http://pubs.rsna.org/doi/10.1148/radiol.12111901 http://pubs.rsna.org/doi/10.1148/radiol.12111901

ZHOU W B , LIANG M D , PAN H , et al . Comparison of ablation zones among different tissues using 2 450 MHz cooled-shaft microwave antenna: results in ex vivo porcine models [J ] . PLoS One , 2013 , 8 ( 8 ): e71873 . DOI: 10.1371/journal.pone.0071873 http://doi.org/10.1371/journal.pone.0071873 https://dx.plos.org/10.1371/journal.pone.0071873 https://dx.plos.org/10.1371/journal.pone.0071873

ZHOU W B , JIANG Y N , CHEN L , et al . Image and pathological changes after microwave ablation of breast cancer: a pilot study [J ] . Eur J Radiol , 2014 , 83 ( 10 ): 1771 - 1777 . DOI: 10.1016/j.ejrad.2014.06.015 http://doi.org/10.1016/j.ejrad.2014.06.015 https://linkinghub.elsevier.com/retrieve/pii/S0720048X14003337 https://linkinghub.elsevier.com/retrieve/pii/S0720048X14003337

ZHOU W B , DING Q , LIU X A , et al . Percutaneous microwave coagulation for eradication of VX2 tumors subcutaneously in rabbits [J ] . World J Surg Oncol , 2012 , 10 : 97 . DOI: 10.1186/1477-7819-10-97 http://doi.org/10.1186/1477-7819-10-97 https://doi.org/10.1186/1477-7819-10-97 https://doi.org/10.1186/1477-7819-10-97

KONG P , CHEN L , SHI X , et al . Microwave ablation combined with doxorubicin enhances cell death via promoting reactive oxygen species generation in breast cancer cells [J ] . Diagn Interv Imaging , 2018 , 99 ( 12 ): 783 - 791 . DOI: 10.1016/j.diii.2018.06.004 http://doi.org/10.1016/j.diii.2018.06.004 https://linkinghub.elsevier.com/retrieve/pii/S2211568418301554 https://linkinghub.elsevier.com/retrieve/pii/S2211568418301554

KONG P , PAN H , YU M , et al . Insufficient microwave ablation-induced promotion of distant metastasis is suppressed by β-catenin pathway inhibition in breast cancer [J ] . Oncotarget , 2017 , 8 ( 70 ): 115089 - 115101 . DOI: 10.18632/oncotarget.22859 http://doi.org/10.18632/oncotarget.22859 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.22859 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.22859

SHI X , PAN H , GE H , et al . Subsequent cooling-circulation after radiofrequency and microwave ablation avoids secondary indirect damage induced by residual thermal energy [J ] . Diagn Interv Radiol , 2019 , 25 ( 4 ): 291 - 297 . DOI: 10.5152/dir.2019.17455 http://doi.org/10.5152/dir.2019.17455 https://www.dirjournal.org/en/subsequent-cooling-circulation-after-radiofrequency-and-microwave-ablation-avoids-secondary-indirect-damage-induced-by-residual-thermal-energy-132088 https://www.dirjournal.org/en/subsequent-cooling-circulation-after-radiofrequency-and-microwave-ablation-avoids-secondary-indirect-damage-induced-by-residual-thermal-energy-132088

ZHOU W B , YU M X , PAN H , et al . Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer [J ] . J Immunother Cancer , 2021 , 9 ( 4 ): e002343 . DOI: 10.1136/jitc-2021-002343 http://doi.org/10.1136/jitc-2021-002343 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-002343 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-002343

TOLBA M F , OMAR H A . Immunotherapy, an evolving approach for the management of triple negative breast cancer: converting non-responders to responders [J ] . Crit Rev Oncol Hematol , 2018 , 122 : 202 - 207 . DOI: 10.1016/j.critrevonc.2018.01.005 http://doi.org/10.1016/j.critrevonc.2018.01.005 https://linkinghub.elsevier.com/retrieve/pii/S1040842817304213 https://linkinghub.elsevier.com/retrieve/pii/S1040842817304213

EMENS L A . Breast cancer immunotherapy: facts and hopes [J ] . Clin Cancer Res , 2018 , 24 ( 3 ): 511 - 520 . DOI: 10.1158/1078-0432.CCR-16-3001 http://doi.org/10.1158/1078-0432.CCR-16-3001 https://aacrjournals.org/clincancerres/article/24/3/511/81112/Breast-Cancer-Immunotherapy-Facts-and-HopesBreast https://aacrjournals.org/clincancerres/article/24/3/511/81112/Breast-Cancer-Immunotherapy-Facts-and-HopesBreast

ROBERT C , RIBAS A , SCHACHTER J , et al . Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study [J ] . Lancet Oncol , 2019 , 20 ( 9 ): 1239 - 1251 . DOI: 10.1016/S1470-2045(19)30388-2 http://doi.org/10.1016/S1470-2045(19)30388-2 https://linkinghub.elsevier.com/retrieve/pii/S1470204519303882 https://linkinghub.elsevier.com/retrieve/pii/S1470204519303882

ROBERT C , THOMAS L , BONDARENKO I , et al . Ipilimumab plus dacarbazine for previously untreated metastatic melanoma [J ] . N Engl J Med , 2011 , 364 ( 26 ): 2517 - 2526 . DOI: 10.1056/NEJMoa1104621 http://doi.org/10.1056/NEJMoa1104621 http://www.nejm.org/doi/abs/10.1056/NEJMoa1104621 http://www.nejm.org/doi/abs/10.1056/NEJMoa1104621

SCHMID P , RUGO H S , ADAMS S , et al . Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial [J ] . Lancet Oncol , 2020 , 21 ( 1 ): 44 - 59 . DOI: 10.1016/S1470-2045(19)30689-8 http://doi.org/10.1016/S1470-2045(19)30689-8 https://linkinghub.elsevier.com/retrieve/pii/S1470204519306898 https://linkinghub.elsevier.com/retrieve/pii/S1470204519306898

EMENS L A , CRUZ C , EDER J P , et al . Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: a phase Ⅰ study [J ] . JAMA Oncol , 2019 , 5 ( 1 ): 74 - 82 . DOI: 10.1001/jamaoncol.2018.4224 http://doi.org/10.1001/jamaoncol.2018.4224 http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2018.4224 http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2018.4224

SCHUMACHER T N , SCHREIBER R D . Neoantigens in cancer immunotherapy [J ] . Science , 2015 , 348 ( 6230 ): 69 - 74 . DOI: 10.1126/science.aaa4971 http://doi.org/10.1126/science.aaa4971 https://www.science.org/doi/10.1126/science.aaa4971 https://www.science.org/doi/10.1126/science.aaa4971

MCARTHUR H L , DIAB A , PAGE D B , et al . A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling [J ] . Clin Cancer Res , 2016 , 22 ( 23 ): 5729 - 5737 . DOI: 10.1158/1078-0432.CCR-16-0190 http://doi.org/10.1158/1078-0432.CCR-16-0190 https://aacrjournals.org/clincancerres/article/22/23/5729/122622/A-Pilot-Study-of-Preoperative-Single-Dose https://aacrjournals.org/clincancerres/article/22/23/5729/122622/A-Pilot-Study-of-Preoperative-Single-Dose

HO A Y , BARKER C A , ARNOLD B B , et al . A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer [J ] . Cancer , 2020 , 126 ( 4 ): 850 - 860 . DOI: 10.1002/cncr.32599 http://doi.org/10.1002/cncr.32599 https://onlinelibrary.wiley.com/doi/10.1002/cncr.32599 https://onlinelibrary.wiley.com/doi/10.1002/cncr.32599

VOORWERK L , SLAGTER M , HORLINGS H M , et al . Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial [J ] . Nat Med , 2019 , 25 ( 6 ): 920 - 928 . DOI: 10.1038/s41591-019-0432-4 http://doi.org/10.1038/s41591-019-0432-4 https://doi.org/10.1038/s41591-019-0432-4 https://doi.org/10.1038/s41591-019-0432-4

DEMARIA S , GOLDEN E B , FORMENTI S C . Role of local radiation therapy in cancer immunotherapy [J ] . JAMA Oncol , 2015 , 1 ( 9 ): 1325 - 1332 . DOI: 10.1001/jamaoncol.2015.2756 http://doi.org/10.1001/jamaoncol.2015.2756 http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.2756 http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.2756

BADWE R , HAWALDAR R , NAIR N , et al . Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial [J ] . Lancet Oncol , 2015 , 16 ( 13 ): 1380 - 1388 . DOI: 10.1016/S1470-2045(15)00135-7 http://doi.org/10.1016/S1470-2045(15)00135-7 https://linkinghub.elsevier.com/retrieve/pii/S1470204515001357 https://linkinghub.elsevier.com/retrieve/pii/S1470204515001357

ZHAO J , WEN X F , TIAN L , et al . Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer [J ] . Nat Commun , 2019 , 10 ( 1 ): 899 . DOI: 10.1038/s41467-019-08782-1 http://doi.org/10.1038/s41467-019-08782-1 https://doi.org/10.1038/s41467-019-08782-1 https://doi.org/10.1038/s41467-019-08782-1

DEN BROK M H M G M , SUTMULLER R P M , VAN DER VOORT R , et al . In situ tumor ablation creates an antigen source for the generation of antitumor immunity [J ] . Cancer Res , 2004 , 64 ( 11 ): 4024 - 4029 . DOI: 10.1158/0008-5472.CAN-03-3949 http://doi.org/10.1158/0008-5472.CAN-03-3949 https://aacrjournals.org/cancerres/article/64/11/4024/511373/In-Situ-Tumor-Ablation-Creates-an-Antigen-Source https://aacrjournals.org/cancerres/article/64/11/4024/511373/In-Situ-Tumor-Ablation-Creates-an-Antigen-Source

FORMENTI S C , DEMARIA S . Systemic effects of local radiotherapy [J ] . Lancet Oncol , 2009 , 10 ( 7 ): 718 - 726 . DOI: 10.1016/S1470-2045(09)70082-8 http://doi.org/10.1016/S1470-2045(09)70082-8 https://linkinghub.elsevier.com/retrieve/pii/S1470204509700828 https://linkinghub.elsevier.com/retrieve/pii/S1470204509700828

SÁNCHEZ-ORTIZ R F , TANNIR N , AHRAR K , et al . Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? [J ] . J Urol , 2003 , 170 ( 1 ): 178 - 179 . DOI: 10.1097/01.ju.0000070823.38336.7b http://doi.org/10.1097/01.ju.0000070823.38336.7b http://www.jurology.com/doi/10.1097/01.ju.0000070823.38336.7b http://www.jurology.com/doi/10.1097/01.ju.0000070823.38336.7b

KIM H , PARK B K , KIM C K . Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma [J ] . Korean J Radiol , 2008 , 9 ( 5 ): 470 - 472 . DOI: 10.3348/kjr.2008.9.5.470 http://doi.org/10.3348/kjr.2008.9.5.470 https://www.kjronline.org/DOIx.php?id=10.3348/kjr.2008.9.5.470 https://www.kjronline.org/DOIx.php?id=10.3348/kjr.2008.9.5.470

SOANES W A , ABLIN R J , GONDER M J . Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations [J ] . J Urol , 1970 , 104 ( 1 ): 154 - 159 . DOI: 10.1016/S0022-5347(17)61690-2 http://doi.org/10.1016/S0022-5347(17)61690-2 http://www.jurology.com/doi/10.1016/S0022-5347%2817%2961690-2 http://www.jurology.com/doi/10.1016/S0022-5347%2817%2961690-2

MCGAHAN J P , BROCK J M , TESLUK H , et al . Hepatic ablation with use of radio-frequency electrocautery in the animal model [J ] . J Vasc Interv Radiol , 1992 , 3 ( 2 ): 291 - 297 . DOI: 10.1016/S1051-0443(92)72028-4 http://doi.org/10.1016/S1051-0443(92)72028-4 https://linkinghub.elsevier.com/retrieve/pii/S1051044392720284 https://linkinghub.elsevier.com/retrieve/pii/S1051044392720284

LI L , WANG W , PAN H , et al . Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer [J ] . J Transl Med , 2017 , 15 ( 1 ): 23 . DOI: 10.1186/s12967-017-1124-9 http://doi.org/10.1186/s12967-017-1124-9 http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1124-9 http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1124-9

ZHU J , YU M , CHEN L , et al . Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: a pre-clinical study in a murine model [J ] . Diagn Interv Imaging , 2018 , 99 ( 3 ): 135 - 142 . DOI: 10.1016/j.diii.2017.12.011 http://doi.org/10.1016/j.diii.2017.12.011 https://linkinghub.elsevier.com/retrieve/pii/S2211568417303418 https://linkinghub.elsevier.com/retrieve/pii/S2211568417303418

ZHOU W B , YU M X , MAO X R , et al . Landscape of the peripheral immune response induced by local microwave ablation in patients with breast cancer [J ] . Adv Sci (Weinh) , 2022 , 9 ( 17 ): e2200033.

HAEN S P , GOUTTEFANGEAS C , SCHMIDT D , et al . Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation [J ] . Cell Stress Chaperones , 2011 , 16 ( 5 ): 495 - 504 . DOI: 10.1007/s12192-011-0261-y http://doi.org/10.1007/s12192-011-0261-y http://link.springer.com/10.1007/s12192-011-0261-y http://link.springer.com/10.1007/s12192-011-0261-y

GU T , GE Y , SONG Y Z , et al . Hepatic radiofrequency ablation causes an increase of circulating histones in patients with hepatocellular carcinoma [J ] . Scand J Clin Lab Invest , 2015 , 75 ( 7 ): 621 - 627 . DOI: 10.3109/00365513.2015.1050689 http://doi.org/10.3109/00365513.2015.1050689 http://www.tandfonline.com/doi/full/10.3109/00365513.2015.1050689 http://www.tandfonline.com/doi/full/10.3109/00365513.2015.1050689

LI G F , STAVELEY-O’CARROLL K F , KIMCHI E T . Potential of radiofrequency ablation in combination with immunotherapy in the treatment of hepatocellular carcinoma [J ] . J Clin Trials , 2016 , 6 ( 2 ): 257 .

浏览量

2790

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

2025年中国乳腺癌重要临床试验成果

中国乳腺癌重要基础转化研究——进展与展望

肿瘤相关中性粒细胞在乳腺癌发生、发展中的作用研究进展

三阴性乳腺癌脑转移治疗的研究进展

2022年中国乳腺癌重要临床试验成果及最新进展